Abstract
In this review, we summarize early pulmonary complications related to cancer therapy in children and highlight characteristic findings on imaging that should be familiar to a radiologist reviewing imaging from pediatric cancer patients.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2017-2028 |
| Number of pages | 12 |
| Journal | Pediatric radiology |
| Volume | 52 |
| Issue number | 10 |
| DOIs | |
| State | Published - Sep 2022 |
Funding
Dr. A. Sharma has received a consultant fee from Spotlight Therapeutics and Medexus Inc. He has also received research funding from CRISPR Therapeutics and honoraria from Vindico Medical Education. He is the St. Jude Children’s Research Hospital site principal investigator of clinical trials for genome editing of sickle cell disease sponsored by Vertex Pharmaceuticals/CRISPR Therapeutics (NCT03745287) and by Novartis (NCT04443907). The industry sponsors provide funding for the clinical trial, which includes salary support paid to Dr. Sharma’s institution. These disclosures are not directly related to the content in this manuscript. Dr. Sharma also acknowledges support from the American Society of Hematology (ASH) Scholar Award. The other authors report no conflicts of interest.
Keywords
- Cancer therapy
- Children
- Complications
- Computed tomography
- Oncology
- Pulmonary
- Thoracic
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Radiology Nuclear Medicine and imaging
